Thrivent Financial for Lutherans Purchases 49,601 Shares of GE HealthCare Technologies Inc. $GEHC

by · The Cerbat Gem

Thrivent Financial for Lutherans lifted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 229.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 71,233 shares of the company’s stock after purchasing an additional 49,601 shares during the period. Thrivent Financial for Lutherans’ holdings in GE HealthCare Technologies were worth $5,277,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Dodge & Cox increased its stake in GE HealthCare Technologies by 42.1% in the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after buying an additional 6,982,441 shares during the last quarter. Norges Bank bought a new position in shares of GE HealthCare Technologies in the second quarter valued at approximately $468,120,000. Holocene Advisors LP increased its position in shares of GE HealthCare Technologies by 178.5% during the second quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock valued at $298,306,000 after acquiring an additional 2,581,522 shares during the last quarter. Menora Mivtachim Holdings LTD. purchased a new stake in shares of GE HealthCare Technologies during the second quarter valued at approximately $80,755,000. Finally, Balyasny Asset Management L.P. bought a new stake in GE HealthCare Technologies during the second quarter worth $58,388,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $82.89 on Friday. The firm has a market capitalization of $37.76 billion, a P/E ratio of 17.13, a P/E/G ratio of 3.44 and a beta of 1.10. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. The stock’s 50-day simple moving average is $77.69 and its two-hundred day simple moving average is $75.39. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. During the same quarter in the prior year, the firm earned $1.14 EPS. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s payout ratio is 2.89%.

Analyst Ratings Changes

GEHC has been the subject of a number of recent analyst reports. Jefferies Financial Group upped their price objective on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. Evercore ISI increased their price target on shares of GE HealthCare Technologies from $88.00 to $92.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Stifel Nicolaus set a $90.00 price objective on shares of GE HealthCare Technologies in a research report on Friday, November 21st. BTIG Research reiterated a “buy” rating and issued a $87.00 target price on shares of GE HealthCare Technologies in a research note on Friday, November 21st. Finally, Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Six equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $87.09.

Check Out Our Latest Stock Report on GE HealthCare Technologies

GE HealthCare Technologies Profile

(Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Read More